BACKGROUND: The hallmark of thoracic aortic aneurysms and dissections (TAAD) is progressive medial degeneration, which can result from excessive tissue destruction and insufficient repair. Although multipotent stem cells (SCs) are important in tissue repair, their role in TAAD is unknown. We sought to determine whether SCs are more abundant in TAAD tissue than in control tissues, and whether SCs within the diseased aortic wall differentiate into functionally relevant cell types. METHODS: Using immunohistochemistry, we compared the abundance of STRO-1+ cells, c-kit+ cells, and CD34+ cells in aortic tissue from patients with descending thoracic aortic aneurysms (n=12), patients with chronic descending thoracic aortic dissections (n=18), and age-matched organ donors (n=5). Using double immunofluorescence staining, we evaluated SC differentiation into smooth muscle cells, fibroblasts, and macrophages. RESULTS: All three cell types were significantly more abundant in the media and adventitia of TAAD tissues than in control tissues. We identified subsets of STRO-1+ cells, c-kit+ cells, and CD34+ cells that also expressed the smooth muscle cell marker SM22-α or fibroblast-specific protein-1, suggesting SC differentiation into smooth muscle cells or fibroblasts. Other STRO-1+ cells expressed the macrophage marker CD68, suggesting differentiation into inflammatory cells. CONCLUSIONS: Stem cells are more abundant in TAAD tissue than in normal aortic tissue. Differentiation of SCs into smooth muscle cells, fibroblasts, and inflammatory cells within the diseased aortic wall suggests that SCs might be involved in both reparative and destructive remodeling processes in TAAD. Understanding the regulation of SC-mediated aortic remodeling will be a critical step toward designing strategies to promote aortic repair and prevent adverse remodeling.
BACKGROUND: The hallmark of thoracic aortic aneurysms and dissections (TAAD) is progressive medial degeneration, which can result from excessive tissue destruction and insufficient repair. Although multipotent stem cells (SCs) are important in tissue repair, their role in TAAD is unknown. We sought to determine whether SCs are more abundant in TAAD tissue than in control tissues, and whether SCs within the diseased aortic wall differentiate into functionally relevant cell types. METHODS: Using immunohistochemistry, we compared the abundance of STRO-1+ cells, c-kit+ cells, and CD34+ cells in aortic tissue from patients with descending thoracic aortic aneurysms (n=12), patients with chronic descending thoracic aortic dissections (n=18), and age-matched organ donors (n=5). Using double immunofluorescence staining, we evaluated SC differentiation into smooth muscle cells, fibroblasts, and macrophages. RESULTS: All three cell types were significantly more abundant in the media and adventitia of TAAD tissues than in control tissues. We identified subsets of STRO-1+ cells, c-kit+ cells, and CD34+ cells that also expressed the smooth muscle cell marker SM22-α or fibroblast-specific protein-1, suggesting SC differentiation into smooth muscle cells or fibroblasts. Other STRO-1+ cells expressed the macrophage marker CD68, suggesting differentiation into inflammatory cells. CONCLUSIONS: Stem cells are more abundant in TAAD tissue than in normal aortic tissue. Differentiation of SCs into smooth muscle cells, fibroblasts, and inflammatory cells within the diseased aortic wall suggests that SCs might be involved in both reparative and destructive remodeling processes in TAAD. Understanding the regulation of SC-mediated aortic remodeling will be a critical step toward designing strategies to promote aortic repair and prevent adverse remodeling.
Authors: P J Psaltis; S Paton; F See; A Arthur; S Martin; S Itescu; S G Worthley; S Gronthos; A C W Zannettino Journal: J Cell Physiol Date: 2010-05 Impact factor: 6.384
Authors: Joe Dawson; Jenny Tooze; Gillian Cockerill; Edward Choke; Ian Loftus; Matt M Thompson Journal: Ann N Y Acad Sci Date: 2006-11 Impact factor: 5.691
Authors: Henry C Quevedo; Konstantinos E Hatzistergos; Behzad N Oskouei; Gary S Feigenbaum; Jose E Rodriguez; David Valdes; Pradip M Pattany; Juan P Zambrano; Qinghua Hu; Ian McNiece; Alan W Heldman; Joshua M Hare Journal: Proc Natl Acad Sci U S A Date: 2009-08-05 Impact factor: 11.205
Authors: Yvonne N Tallini; Kai Su Greene; Michael Craven; Alyson Spealman; Martin Breitbach; James Smith; Patricia J Fisher; Michele Steffey; Michael Hesse; Robert M Doran; Ashley Woods; Babu Singh; Andrew Yen; Bernd K Fleischmann; Michael I Kotlikoff Journal: Proc Natl Acad Sci U S A Date: 2009-02-04 Impact factor: 11.205
Authors: Sili Zou; Pingping Ren; Lin Zhang; Alon R Azares; Sui Zhang; Joseph S Coselli; Ying H Shen; Scott A LeMaire Journal: J Surg Res Date: 2019-08-05 Impact factor: 2.192
Authors: Marie Billaud; Vera S Donnenberg; Bradley W Ellis; E Michael Meyer; Albert D Donnenberg; Jennifer C Hill; Tara D Richards; Thomas G Gleason; Julie A Phillippi Journal: Stem Cell Reports Date: 2017-05-25 Impact factor: 7.765
Authors: Aldo Rocca; Domenico Tafuri; Marianna Paccone; Antonio Giuliani; Anna Ginevra Immacolata Zamboli; Giuseppe Surfaro; Andrea Paccone; Rita Compagna; Maurizo Amato; Raffaele Serra; Bruno Amato Journal: Open Med (Wars) Date: 2017-10-21